BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 33841445)

  • 1. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
    Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
    Front Immunol; 2021; 12():662866. PubMed ID: 33841445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of migratory and prosurvival pathways induced by the homeostatic chemokines CCL19 and CCL21 in B-cell chronic lymphocytic leukemia.
    Cuesta-Mateos C; López-Giral S; Alfonso-Pérez M; de Soria VG; Loscertales J; Guasch-Vidal S; Beltrán AE; Zapata JM; Muñoz-Calleja C
    Exp Hematol; 2010 Sep; 38(9):756-64, 764.e1-4. PubMed ID: 20488224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ibrutinib on CCR7 expression and functionality in chronic lymphocytic leukemia and its implication for the activity of CAP-100, a novel therapeutic anti-CCR7 antibody.
    Mateu-Albero T; Juárez-Sánchez R; Loscertales J; Mol W; Terrón F; Muñoz-Calleja C; Cuesta-Mateos C
    Cancer Immunol Immunother; 2022 Mar; 71(3):627-636. PubMed ID: 34297159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma.
    Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM
    Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting cancer homing into the lymph node with a novel anti-CCR7 therapeutic antibody: the paradigm of CLL.
    Cuesta-Mateos C; Juárez-Sánchez R; Mateu-Albero T; Loscertales J; Mol W; Terrón F; Muñoz-Calleja C
    MAbs; 2021; 13(1):1917484. PubMed ID: 33944659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced Chemokine Receptor Recycling and Impaired S1P1 Expression Promote Leukemic Cell Infiltration of Lymph Nodes in Chronic Lymphocytic Leukemia.
    Patrussi L; Capitani N; Martini V; Pizzi M; Trimarco V; Frezzato F; Marino F; Semenzato G; Trentin L; Baldari CT
    Cancer Res; 2015 Oct; 75(19):4153-63. PubMed ID: 26282174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemokine receptor CCR7 and alpha4 integrin are important for migration of chronic lymphocytic leukemia cells into lymph nodes.
    Till KJ; Lin K; Zuzel M; Cawley JC
    Blood; 2002 Apr; 99(8):2977-84. PubMed ID: 11929789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the atypical chemoattractant receptor CRAM in regulating CCL19 induced CCR7 responses in B-cell chronic lymphocytic leukemia.
    Catusse J; Leick M; Groch M; Clark DJ; Buchner MV; Zirlik K; Burger M
    Mol Cancer; 2010 Nov; 9():297. PubMed ID: 21092185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
    Giannoni P; Cutrona G; Totero D
    Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nurselike cells sequester B cells in disorganized lymph nodes in chronic lymphocytic leukemia via alternative production of CCL21.
    Zaaboub R; Vimeux L; Contremoulins V; Cymbalista F; Lévy V; Donnadieu E; Varin-Blank N; Martin A; Dondi E
    Blood Adv; 2022 Aug; 6(16):4691-4704. PubMed ID: 35679464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZAP70 expression enhances chemokine-driven chronic lymphocytic leukemia cell migration and arrest by valency regulation of integrins.
    Laufer JM; Lyck R; Legler DF
    FASEB J; 2018 Sep; 32(9):4824-4835. PubMed ID: 29589978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
    Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
    Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lymph node microenvironment promotes B-cell receptor signaling, NF-kappaB activation, and tumor proliferation in chronic lymphocytic leukemia.
    Herishanu Y; Pérez-Galán P; Liu D; Biancotto A; Pittaluga S; Vire B; Gibellini F; Njuguna N; Lee E; Stennett L; Raghavachari N; Liu P; McCoy JP; Raffeld M; Stetler-Stevenson M; Yuan C; Sherry R; Arthur DC; Maric I; White T; Marti GE; Munson P; Wilson WH; Wiestner A
    Blood; 2011 Jan; 117(2):563-74. PubMed ID: 20940416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 is up-regulated by CCL21/CCR7 interaction via extracellular signal-regulated kinase-1/2 signaling and is involved in CCL21-driven B-cell chronic lymphocytic leukemia cell invasion and migration.
    Redondo-Muñoz J; José Terol M; García-Marco JA; García-Pardo A
    Blood; 2008 Jan; 111(1):383-6. PubMed ID: 17890452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p66Shc deficiency enhances CXCR4 and CCR7 recycling in CLL B cells by facilitating their dephosphorylation-dependent release from β-arrestin at early endosomes.
    Patrussi L; Capitani N; Cattaneo F; Manganaro N; Gamberucci A; Frezzato F; Martini V; Visentin A; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Baldari CT
    Oncogene; 2018 Mar; 37(11):1534-1550. PubMed ID: 29326436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokine receptors that mediate B cell homing to secondary lymphoid tissues are highly expressed in B cell chronic lymphocytic leukemia and non-Hodgkin lymphomas with widespread nodular dissemination.
    López-Giral S; Quintana NE; Cabrerizo M; Alfonso-Pérez M; Sala-Valdés M; De Soria VG; Fernández-Rañada JM; Fernández-Ruiz E; Muñoz C
    J Leukoc Biol; 2004 Aug; 76(2):462-71. PubMed ID: 15155773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates.
    Hartmann EM; Rudelius M; Burger JA; Rosenwald A
    Leuk Lymphoma; 2016; 57(3):563-71. PubMed ID: 26458057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
    Risnik D; Colado A; Podaza E; Almejún MB; Elías EE; Bezares RF; Fernández-Grecco H; Seija N; Oppezzo P; Borge M; Gamberale R; Giordano M
    Cancer Immunol Immunother; 2020 May; 69(5):813-824. PubMed ID: 32055920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.
    Hayden RE; Pratt G; Roberts C; Drayson MT; Bunce CM
    Leuk Lymphoma; 2012 Apr; 53(4):537-49. PubMed ID: 21812539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment.
    Ferretti E; Bertolotto M; Deaglio S; Tripodo C; Ribatti D; Audrito V; Blengio F; Matis S; Zupo S; Rossi D; Ottonello L; Gaidano G; Malavasi F; Pistoia V; Corcione A
    Leukemia; 2011 Aug; 25(8):1268-77. PubMed ID: 21546901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.